ARM Holdings plc: Form 20-F for the period ended Mar 31, 2024
Filed with the SEC on May 29, 2024 and accepted by EDGAR at May 29, 2024, 16:05 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-04-01 to 2024-03-31 | $3.23bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2023-04-01 to 2024-03-31 | $154.0m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2023-04-01 to 2024-03-31 | $3.08bn | us-gaap:GrossProfit |
| Research and development | 12 months2023-04-01 to 2024-03-31 | $1.98bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2023-04-01 to 2024-03-31 | $983.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2023-04-01 to 2024-03-31 | $111.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2023-04-01 to 2024-03-31 | −$93.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2023-04-01 to 2024-03-31 | $306.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2023-04-01 to 2024-03-31 | $0.29 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2023-04-01 to 2024-03-31 | $0.30 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2023-04-01 to 2024-03-31 | 1,044,497,032 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-04-01 to 2024-03-31 | $1.09bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2023-04-01 to 2024-03-31 | $92.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2024-03-31 | $1.92bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $4.20bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $7.93bn | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $1.50bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $2.63bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-03-31 | $5.29bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2024-03-31 | 1,040,330,497 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001973239-24-000012. Last ingested by Listed: Nov 4, 2026, 16:46 ET. Listed shows no prices and gives no investment advice.